Skip to main content
Log in

Mismatch of vaccine influenza B lineages is costly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Funding provided by GlaxoSmithKline Biologicals SA.

  2. all influenza strains combined

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mismatch of vaccine influenza B lineages is costly. PharmacoEcon Outcomes News 681, 8 (2013). https://doi.org/10.1007/s40274-013-0515-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0515-2

Navigation